Industry and academia are increasingly complexifying their in vitro models, not only 3D models but also organs-on-chip (OoC) in their studies. Such systems are needed for putting different tissues into contact, or to take into account flux-related aspects.

BIOMIMESYS® being an ideal hydroscaffold™ for 3D cell culture, this webinar aims at demonstrating its compatibility with OoCs, and showing examples of use of this matrix to integrate the 3D in OoCs, In particular, we will show results obtained in toxicology (BIOMIMESYS® Liver) and oncology (BIOMIMESYS® Oncology) projects, obtained in-house in HCS Pharma or through collaborations.

Registration is close, the webinar is available here.

This image used for this post was originally posted to Flickr by NIH-NCATS at https://flickr.com/photos/64860478@N05/41427884275 (archive). It was reviewed on 10 July 2018 by FlickreviewR 2 and was confirmed to be licensed under the terms of the cc-by-2.0.


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.